Clinical Trials Browser

INDUSTRY × Neoplasms × siplizumab × Clear all

NCT00806728 2008-12-11

Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease

Phase 1 Completed

Graft vs Host Disease, Neoplasms

NCT00105313 2007-06-14

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Neoplasms